Combating Counterfeit and Diverted Drugs: A Lipitor Case Study and Top 10 Strategies for Protecting Your Products  
  SEARCH: Sign In | Register | Contact Us | Site Map | Home  

Events for Food and Drug Administration (FDA)

Combating Counterfeit and Diverted Drugs: A Lipitor Case Study and Top 10 Strategies for Protecting Your Products

Company:FDANews
Event Start:   2008-05-14 01:30 Eastern
Event End:2008-05-14
Location:None

Sign up your entire team to listen in and discover:

* Lessons learned from the Lipitor case and five best practices to identify counterfeit schemes
* The extent and depth of the drug-counterfeiting problem and which drug classes are next
* The industry's role in fighting counterfeiting
* What effect counterfeiting has on your relationship with wholesalers and pharmacies
* Top 10 ways fake drugs wind up in legitimate supply chains
* The next breed of counterfeiters and what they have in mind
* New ideas for getting inside the minds of counterfeiters
* What the government is doing — and not doing — about the problem
* Three not-so-obvious reasons for lack of news coverage of counterfeiters, even when they get caught
* The latest initiatives and resources the industry is bringing to bear to fight counterfeiters

View the Event



Share or bookmarklet this web page at:





Google
Privacy Policy | Terms & Conditions | Support | Directory Links | Contact Us | Site Map | Home
Copyright © 2007-2008 ComplianceHome.com. A SUPREMUS GROUP venture. All rights reserved.